A new standard of care for treatment of ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference22 articles.
1. Chemotherapy in advanced ovarian cancer;Br. J. Med.,1991
2. A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin and cyclophosphamide in advanced ovarian cancer;Conte;J. Clin. Oncol.,1986
3. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma;Omura;J. Clin. Oncol.,1989
4. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer;Lancet,1987
5. Impact of doxorubicin on survival in advanced ovarian cancer;A'hern;J. Clin. Oncol.,1995
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long Noncoding RNA LINC01125 Enhances Cisplatin Sensitivity of Ovarian Cancer via miR-1972;Medical Science Monitor;2019-12-22
2. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas;Cancer Biology & Therapy;2019-03-01
3. Non-pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial;Oncology Letters;2016-06-16
4. Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study;International Journal of Gynecologic Cancer;2016-01-01
5. Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer;Archives of Gynecology and Obstetrics;2015-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3